New therapeutic may benefit DME in the long term
Research

New therapeutic may benefit DME in the long term

Phase 1 study data suggests intravitreal injection of novel senolytic therapy is safe and effective in treating DME.
Nicox selects biotech exec for CEO as clinical focus shifts
Business

Nicox selects biotech exec for CEO as clinical focus shifts

Effective Feb. 29, Gavin Spencer, PhD, has taken the helm while the company announces corporate debt restructuring.
Vision Expo East 2024 to feature expansive CE opportunities
Events

Vision Expo East 2024 to feature expansive CE opportunities

Last-ever NYC-based trade conference promises 100+ hours of education for ODs, opticians, and allied health professionals. 
IRIS Registry identifies key factors for post-cataract IOP spikes
Research

IRIS Registry identifies key factors for post-cataract IOP spikes

IOP spikes occurred at a rate of 3.7% following standalone phacoemulsification.
FDA sends warning letters to 4 eye drop manufacturers, distributors
Products

FDA sends warning letters to 4 eye drop manufacturers, distributors

Agency cited multiple violations for EzriCare, Delsam Pharma, LightEyez, and Amman Pharmaceuticals.
Multiprovider financing now available for CoFi's CareCredit credit card
Products

Multiprovider financing now available for CoFi's CareCredit credit card

Healthcare software platform is officially allowing multi-party payments across the market.
Does gender impact the risk for myopia development?
Research

Does gender impact the risk for myopia development?

Cross-sectional study explores sex-specific risk factors of myopia.
CorNeat Everpatch for ophthalmic surgery launches in the US
Products

CorNeat Everpatch for ophthalmic surgery launches in the US

First-ever synthetic tissue substitute is designed for use in ophthalmic surgeries.
Skye Bioscience concludes enrollment for phase 2 glaucoma, OHT trial
Pipeline

Skye Bioscience concludes enrollment for phase 2 glaucoma, OHT trial

Study is evaluating SBI-100 ophthalmic emulsion, formulated to modulate IOP.
Nanodropper's eyedrop adaptor is heading to space
Products

Nanodropper's eyedrop adaptor is heading to space

Company's flagship product is scheduled to launch on March 2, with plans to undergo microgravity testing.
Eric Donnenfeld, MD, joins Nordic Group as chair of Medical Advisory Board
Business

Eric Donnenfeld, MD, joins Nordic Group as chair of Medical Advisory Board

Appointment coincides with preparations for launch of LACRIFILL, a cross-linked hyaluronic acid-based canalicular occlusive device for DED.
Voluntary recall issued for eye ointments due to lack of sterility
Products

Voluntary recall issued for eye ointments due to lack of sterility

Four products from an India-based manufacturer were being distributed across the U.S. via CVS and Walmart.
Prevent Blindness kicks off ROP Awareness Week with new program
Events

Prevent Blindness kicks off ROP Awareness Week with new program

First annual awareness week features education program and dedicated video series.
WashU receives $20M to fund development of portable OCT system
Research

WashU receives $20M to fund development of portable OCT system

Technology will be designed to capture high-resolution 3D retina scans in less than 1 second, 50 times faster than standard scanners.
Alan Kabat, OD, FAAO, joins Eyes On Eyecare as Associate Director of Medical Communications
Business

Alan Kabat, OD, FAAO, joins Eyes On Eyecare as Associate Director of Medical Communications

Eyes On Eyecare adds industry veteran to growing team of eyecare specialists.
Investigators develop three new AL progression trajectories
Research

Investigators develop three new AL progression trajectories

Cohort study determines trajectories that may assist treatment of high myopia. 
AI system found to match and surpass human ophthalmologists
Research

AI system found to match and surpass human ophthalmologists

Findings from a comparative study of chatbot vs glaucoma and retina specialists support the potential for future integration into clinical practice.
Eversight and Emmecell Biotech partner on advanced regenerative ocular cell therapy
Research

Eversight and Emmecell Biotech partner on advanced regenerative ocular cell therapy

Phase 1b trial will study Emmecell’s minimally-invasive cell therapy as an alternative to transplantation.
ChatGPT gets tested on ophthalmologic subspecialty accuracy
Research

ChatGPT gets tested on ophthalmologic subspecialty accuracy

Responses to questions about common ophthalmic diseases range from accurate and helpful to incomplete and potentially harmful.
FTC sends claim forms in LasikPlus provider settlement to consumers
Legal

FTC sends claim forms in LasikPlus provider settlement to consumers

Eligible consumers include those who were tricked by deceptive ‘bait-and-switch’ advertising for LASIK procedures.